Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Cardiology Training in Brazil and Developed Countries: Some Ideas for Improvement.

Godoy LC, Farkouh ME, Manta ICKA, Dalçóquio TF, Furtado RHM, Yu EHC, Gun C, Nicolau JC.

Arq Bras Cardiol. 2019 Nov 4;113(4):768-774. doi: 10.5935/abc.20190212. eCollection 2019. English, Portuguese.

2.

Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial.

Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K; FIBRES Research Group.

JAMA. 2019 Oct 21:1-11. doi: 10.1001/jama.2019.17312. [Epub ahead of print]

PMID:
31634905
3.

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.

Qintar M, Humphries KH, Park JE, Arnold SV, Tang Y, Jones P, Salisbury AC, Kureshi F, Farkouh ME, Fuster V, Cohen DJ, Spertus JA.

J Am Coll Cardiol. 2019 Oct 22;74(16):2074-2084. doi: 10.1016/j.jacc.2019.07.083.

PMID:
31623766
4.

Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus.

Godoy LC, Tavares CAM, Farkouh ME.

Can J Diabetes. 2019 Aug 19. pii: S1499-2671(19)30590-8. doi: 10.1016/j.jcjd.2019.08.002. [Epub ahead of print] Review.

PMID:
31594759
5.

Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.

Godoy LC, Rao V, Farkouh ME.

Circulation. 2019 Oct 8;140(15):1233-1235. doi: 10.1161/CIRCULATIONAHA.119.040683. Epub 2019 Oct 7. No abstract available.

PMID:
31589487
6.

PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.

Mefford MT, Marcovina SM, Bittner V, Cushman M, Brown TM, Farkouh ME, Tsimikas S, Monda KL, López JAG, Muntner P, Rosenson RS.

J Lipid Res. 2019 Nov;60(11):1946-1952. doi: 10.1194/jlr.P119000173. Epub 2019 Sep 11.

PMID:
31511398
7.

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.

Sparrow RT, Khan AM, Ferreira-Legere LE, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA.

JAMA Cardiol. 2019 Aug 28. doi: 10.1001/jamacardio.2019.3066. [Epub ahead of print]

PMID:
31461127
8.

Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.

Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA; EMPA-HEART CardioLink-6 Investigators.

Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375. [Epub ahead of print]

PMID:
31434508
9.

The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease.

Godoy LC, Ko DT, Rao V, Farkouh ME.

Prog Cardiovasc Dis. 2019 Jul - Aug;62(4):358-363. doi: 10.1016/j.pcad.2019.07.004. Epub 2019 Aug 1. Review.

PMID:
31377224
10.

Urgent Revascularization Strategies in Patients With Diabetes Mellitus and Acute Coronary Syndrome.

Godoy LC, Lawler PR, Farkouh ME, Hersen B, Nicolau JC, Rao V.

Can J Cardiol. 2019 Aug;35(8):993-1001. doi: 10.1016/j.cjca.2019.03.010. Epub 2019 Mar 20. Review.

PMID:
31376910
11.

Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes.

Gaudino M, Angiolillo DJ, Di Franco A, Capodanno D, Bakaeen F, Farkouh ME, Fremes SE, Holmes D, Girardi LN, Nakamura S, Head SJ, Park SJ, Mack M, Serruys PW, Ruel M, Stone GW, Tam DY, Vallely M, Taggart DP.

J Am Heart Assoc. 2019 Jul 2;8(13):e013032. doi: 10.1161/JAHA.119.013032. Epub 2019 Jun 27. No abstract available.

12.

Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.

Arbel Y, Fuster V, Baber U, Hamza TH, Siami FS, Farkouh ME.

Int J Cardiol. 2019 Oct 15;293:197-202. doi: 10.1016/j.ijcard.2019.05.064. Epub 2019 Jun 13.

PMID:
31230933
13.

Lifestyle Interventions in Diabetes and Coronary Disease: A Timely Reminder.

Farkouh ME, Godoy LC.

J Am Coll Cardiol. 2019 Apr 30;73(16):2059-2061. doi: 10.1016/j.jacc.2018.12.091. No abstract available.

PMID:
31023429
14.

Surgical vs percutaneous coronary revascularization in patients with diabetes following an acute coronary syndrome.

Godoy LC, Farkouh ME.

J Diabetes. 2019 Jul;11(7):610-612. doi: 10.1111/1753-0407.12917. Epub 2019 Apr 22. No abstract available.

PMID:
31012248
15.

Clopidogrel Pharmacogenetics.

Pereira NL, Rihal CS, So DYF, Rosenberg Y, Lennon RJ, Mathew V, Goodman SG, Weinshilboum RM, Wang L, Baudhuin LM, Lerman A, Hasan A, Iturriaga E, Fu YP, Geller N, Bailey K, Farkouh ME.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007811. doi: 10.1161/CIRCINTERVENTIONS.119.007811.

PMID:
30998396
16.

Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario.

Donio PJ, Freitas C, Austin PC, Ross HJ, Abdel-Qadir HM, Wijeysundera HC, Tu K, Cram P, Liu P, Abrams H, Udell JA, Mak S, Farkouh ME, Tu JV, Wang X, Tobe SW, Lee DS.

Can J Cardiol. 2019 Mar;35(3):341-351. doi: 10.1016/j.cjca.2019.01.004.

PMID:
30825954
17.

Editorial commentary: Imaging the aorta for inflammation: Informing practice on emerging molecular techniques.

Veit-Haibach P, Ellaban H, Farkouh ME.

Trends Cardiovasc Med. 2019 Nov;29(8):449-450. doi: 10.1016/j.tcm.2019.01.008. Epub 2019 Feb 5. No abstract available.

PMID:
30770175
18.

Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.

Colantonio LD, Monda KL, Rosenson RS, Brown TM, Mues KE, Howard G, Safford MM, Yedigarova L, Farkouh ME, Muntner P.

Cardiovasc Drugs Ther. 2019 Apr;33(2):189-199. doi: 10.1007/s10557-019-06864-2.

PMID:
30746585
19.

Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.

Farkouh ME, Sidhu MS, Brooks MM, Vlachos H, Boden WE, Frye RL, Hartigan P, Siami FS, Bittner VA, Chaitman BR, Mancini GBJ, Fuster V.

J Am Coll Cardiol. 2019 Feb 5;73(4):400-411. doi: 10.1016/j.jacc.2018.11.044.

PMID:
30704571
20.

Adherence to Statin Therapy Among US Adults Between 2007 and 2014.

Colantonio LD, Rosenson RS, Deng L, Monda KL, Dai Y, Farkouh ME, Safford MM, Philip K, Mues KE, Muntner P.

J Am Heart Assoc. 2019 Jan 8;8(1):e010376. doi: 10.1161/JAHA.118.010376.

21.

Myocardial Revascularization Trials.

Ruel M, Falk V, Farkouh ME, Freemantle N, Gaudino MF, Glineur D, Cameron DE, Taggart DP.

Circulation. 2018 Dec 18;138(25):2943-2951. doi: 10.1161/CIRCULATIONAHA.118.035970. Review.

PMID:
30566019
22.

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.

Esper RB, Farkouh ME, Ribeiro EE, Hueb W, Domanski M, Hamza TH, Siami FS, Godoy LC, Mathew V, French J, Fuster V.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2826-2837. doi: 10.1016/j.jacc.2018.09.046.

PMID:
30522646
23.

The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.

Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, White H, Chuang AM, Tiver K, Quinn S, Kaambwa B, Horsfall M, Morton E, Chew DP.

Am Heart J. 2019 Feb;208:11-20. doi: 10.1016/j.ahj.2018.09.016. Epub 2018 Oct 25.

PMID:
30522086
24.

Right ventricular fibrosis is associated with cardiac remodelling after pulmonary valve replacement.

Yamamura K, Yuen D, Hickey EJ, He X, Chaturvedi RR, Friedberg MK, Grosse-Wortmann L, Hanneman K, Billia F, Farkouh ME, Wald RM.

Heart. 2019 Jun;105(11):855-863. doi: 10.1136/heartjnl-2018-313961. Epub 2018 Dec 4.

PMID:
30514732
25.

Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease.

Domanski MJ, Farkouh ME.

Circulation. 2018 Nov 6;138(19):2079-2080. doi: 10.1161/CIRCULATIONAHA.117.030840. No abstract available.

PMID:
30474419
26.

Reply: Stroke Risk Following Anaortic Off-Pump CABG Versus PCI.

Head SJ, Milojevic M, Domanski MJ, Farkouh ME, Kappetein AP.

J Am Coll Cardiol. 2018 Nov 27;72(21):2681. doi: 10.1016/j.jacc.2018.09.033. No abstract available.

PMID:
30466530
27.

Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.

Colantonio LD, Deng L, Chen L, Farkouh ME, Monda KL, Harrison DJ, Maya JF, Kilgore ML, Muntner P, Rosenson RS.

Cardiovasc Drugs Ther. 2018 Dec;32(6):601-610. doi: 10.1007/s10557-018-6840-8.

PMID:
30446883
28.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.

Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, Hamza TH, Shah B, Stefanini GG, Sidhu MS, Tanguay JF, Ramanathan K, Sharma SK, French J, Hueb W, Cohen DJ, Fuster V; FREEDOM Follow-On Study Investigators.

J Am Coll Cardiol. 2019 Feb 19;73(6):629-638. doi: 10.1016/j.jacc.2018.11.001. Epub 2018 Nov 11.

29.

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S.

J Am Coll Cardiol. 2018 Oct 23;72(17):2071-2081. doi: 10.1016/j.jacc.2018.08.1043. Review.

30.

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

Bain SC, Mosenzon O, Arechavaleta R, Bogdański P, Comlekci A, Consoli A, Deerochanawong C, Dungan K, Faingold MC, Farkouh ME, Franco DR, Gram J, Guja C, Joshi P, Malek R, Merino-Torres JF, Nauck MA, Pedersen SD, Sheu WH, Silver RJ, Tack CJ, Tandon N, Jeppesen OK, Strange M, Thomsen M, Husain M.

Diabetes Obes Metab. 2019 Mar;21(3):499-508. doi: 10.1111/dom.13553. Epub 2018 Nov 11.

31.

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.

Hall M, Bebb OJ, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, Brieger D, Batin PD, Farkouh ME, Hemingway H, Timmis A, Fox KAA, Gale CP.

Eur Heart J. 2018 Nov 7;39(42):3798-3806. doi: 10.1093/eurheartj/ehy517.

32.

Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial.

Scudeler TL, Hueb WA, Farkouh ME, Maron DJ, de Soárez PC, Campolina AG, Takiuti ME, Rezende PC, Godoy LC, Hueb AC, Lima EG, Garzillo CL, Ramires JAF, Kalil Filho R.

Int J Cardiol. 2018 Dec 15;273:63-68. doi: 10.1016/j.ijcard.2018.08.044. Epub 2018 Aug 15.

PMID:
30158068
33.

Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.

Giustino G, Colantonio LD, Brown TM, Carson AP, Dai Y, Farkouh ME, Monda KL, Muntner P, Rosenson RS.

Cardiovasc Drugs Ther. 2018 Oct;32(5):453-461. doi: 10.1007/s10557-018-6816-8.

PMID:
30078077
34.

Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study).

Mefford MT, Tajeu GS, Tanner RM, Colantonio LD, Monda KL, Dent R, Farkouh ME, Rosenson RS, Safford MM, Muntner P.

Am J Cardiol. 2018 Sep 1;122(5):768-774. doi: 10.1016/j.amjcard.2018.05.016. Epub 2018 Jun 2.

PMID:
30057227
35.

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP.

J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.

36.

Diabetes and multivessel disease: coronary artery bypass grafting remains king.

Godoy LC, Rao V, Farkouh ME.

Curr Opin Cardiol. 2018 Sep;33(5):551-557. doi: 10.1097/HCO.0000000000000550. Review.

PMID:
29994804
37.

Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome.

Paruchuri V, Gaztanaga J, Rambhujun V, Smith R, Farkouh ME.

Cardiovasc Drugs Ther. 2018 Dec;32(6):611-616. doi: 10.1007/s10557-018-6798-6.

PMID:
29948740
38.

High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial.

Vardeny O, Udell JA, Joseph J, Farkouh ME, Hernandez AF, McGeer AJ, Talbot HK, Bhatt DL, Cannon CP, Goodman SG, Anand I, DeMets DL, Temte J, Wittes J, Nichol K, Yancy CW, Gaziano JM, Cooper LS, Kim K, Solomon SD.

Am Heart J. 2018 Aug;202:97-103. doi: 10.1016/j.ahj.2018.05.007. Epub 2018 May 23.

39.

Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery.

Sun LY, Chung AM, Farkouh ME, van Diepen S, Weinberger J, Bourke M, Ruel M.

Anesthesiology. 2018 Sep;129(3):440-447. doi: 10.1097/ALN.0000000000002298. Erratum in: Anesthesiology. 2019 Feb;130(2):360.

PMID:
29889106
40.

Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL.

Farkouh ME, Verma S.

J Am Coll Cardiol. 2018 Jun 5;71(22):2507-2510. doi: 10.1016/j.jacc.2018.02.078. No abstract available.

41.

Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS.

Verma S, Mathew V, Farkouh ME.

J Am Coll Cardiol. 2018 May 29;71(21):2402-2404. doi: 10.1016/j.jacc.2018.03.480. No abstract available.

42.

Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.

Al Halabi S, Newman J, Farkouh ME, Fortuin D, Leya F, Sweeney J, Darki A, Lopez J, Steen L, Lewis B, Webb J, Leon MB, Mathew V.

Am J Cardiol. 2018 Jul 1;122(1):141-148. doi: 10.1016/j.amjcard.2018.03.019. Epub 2018 Mar 28. Review.

PMID:
29779587
43.
44.

Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.

Peters SAE, Colantonio LD, Zhao H, Bittner V, Dai Y, Farkouh ME, Monda KL, Safford MM, Muntner P, Woodward M.

J Am Coll Cardiol. 2018 Apr 24;71(16):1729-1737. doi: 10.1016/j.jacc.2018.02.032.

45.

Old Drugs for New Indications in Cardiovascular Medicine.

Arbel Y, Abuzeid W, Rosenson RS, Weisman A, Farkouh ME.

Cardiovasc Drugs Ther. 2018 Apr;32(2):223-232. doi: 10.1007/s10557-018-6785-y. Review.

PMID:
29633048
46.

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP.

Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23. Review. Erratum in: Lancet. 2018 Aug 11;392(10146):476.

PMID:
29478841
47.

Moving Beyond the Stent: Identifying the Percutaneous Coronary Intervention Patient With Silent Diabetes and Pre-Diabetes.

Farkouh ME.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):460-461. doi: 10.1016/j.jcin.2018.01.230. Epub 2018 Feb 14. No abstract available.

48.

Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.

Pinho-Gomes AC, Azevedo L, Ahn JM, Park SJ, Hamza TH, Farkouh ME, Serruys PW, Milojevic M, Kappetein AP, Stone GW, Lamy A, Fuster V, Taggart DP.

J Am Coll Cardiol. 2018 Feb 13;71(6):591-602. doi: 10.1016/j.jacc.2017.11.068.

49.

Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.

Ramanathan K, Abel JG, Park JE, Fung A, Mathew V, Taylor CM, Mancini GBJ, Gao M, Ding L, Verma S, Humphries KH, Farkouh ME.

J Am Coll Cardiol. 2017 Dec 19;70(24):2995-3006. doi: 10.1016/j.jacc.2017.10.029.

50.

Supplemental Content

Loading ...
Support Center